Australian Prostate Cancer BioResource (APCB) Australia

Research

Date range: 1 April 2021 - 31 March 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Australian Prostate Cancer BioResource (APCB) published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Australian Prostate Cancer BioResource (APCB)
Count Share
1 0.03

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.03

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.00 0.00

Compare Australian Prostate Cancer BioResource (APCB) with other institutions

Collaboration

Date range: 1 April 2021 - 31 March 2022

International vs. domestic collaboration by Share

  • 89.89% Domestic
  • 10.11% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Australian Prostate Cancer BioResource (APCB) by Share (15 total)

  1. Australian Prostate Cancer BioResource (APCB) and Monash University (0.44)
    Australian Prostate Cancer BioResource (APCB)0.03
    Monash University0.42
  2. Australian Prostate Cancer BioResource (APCB) and Peter MacCallum Cancer Centre (Peter Mac) (0.22)
    Australian Prostate Cancer BioResource (APCB)0.03
    Peter MacCallum Cancer Centre (Peter Mac)0.20
  3. Australian Prostate Cancer BioResource (APCB) and The University of Melbourne (UniMelb) (0.17)
    Australian Prostate Cancer BioResource (APCB)0.03
    The University of Melbourne (UniMelb)0.14
  4. Australian Prostate Cancer BioResource (APCB) and TissuPath Pty Ltd. (0.10)
    Australian Prostate Cancer BioResource (APCB)0.03
    TissuPath Pty Ltd.0.08
  5. Australian Prostate Cancer BioResource (APCB) and Epworth HealthCare (0.07)
    Australian Prostate Cancer BioResource (APCB)0.03
    Epworth HealthCare0.05
  6. Australian Prostate Cancer BioResource (APCB) and Monash Health (0.07)
    Australian Prostate Cancer BioResource (APCB)0.03
    Monash Health0.04
  7. Australian Prostate Cancer BioResource (APCB) and Australian Urology Associates (AUA Urology) (0.04)
    Australian Prostate Cancer BioResource (APCB)0.03
    Australian Urology Associates (AUA Urology)0.02
  8. Australian Prostate Cancer BioResource (APCB) and Eastern Health (0.03)
    Australian Prostate Cancer BioResource (APCB)0.03
    Eastern Health0.01
  9. Australian Prostate Cancer BioResource (APCB) and Garvan Institute of Medical Research (0.03)
    Australian Prostate Cancer BioResource (APCB)0.03
    Garvan Institute of Medical Research0.01
  10. Australian Prostate Cancer BioResource (APCB) and Austin Health (0.03)
    Australian Prostate Cancer BioResource (APCB)0.03
    Austin Health0.01

Top 10 international collaborators with Australian Prostate Cancer BioResource (APCB) by Share (4 total)

  1. Australian Prostate Cancer BioResource (APCB) and Duke-NUS Medical School (0.05)
    Australian Prostate Cancer BioResource (APCB)0.03
    Duke-NUS Medical School0.02
  2. Australian Prostate Cancer BioResource (APCB) and National University of Singapore (NUS) (0.04)
    Australian Prostate Cancer BioResource (APCB)0.03
    National University of Singapore (NUS)0.01
  3. Australian Prostate Cancer BioResource (APCB) and Duke University (0.04)
    Australian Prostate Cancer BioResource (APCB)0.03
    Duke University0.01
  4. Australian Prostate Cancer BioResource (APCB) and Sheffield Teaching Hospitals NHS Foundation Trust (0.03)
    Australian Prostate Cancer BioResource (APCB)0.03
    Sheffield Teaching Hospitals NHS Foundation Trust0.01

Relationships

Partner Institutions

Australian Prostate Cancer BioResource (APCB) is a research collaboration whose article contributions are accrued to its participating partner institutions below.